Deal Snapshot
CANADIAN BIOCEUTICAL TO ACQUIRE CANNABIS FIRMS N ARIZONA AND MARYLAND
Friday 19 May 2017

Canadian cannabis industry real estate and services provider The Canadian Bioceutical Corp. (CSE: BCC) (OTC: CBICF) has signed non-binding letters of intent to acquire up to four cannabis enterprises in Arizona and Maryland, the company said.
In compliance with Arizona and Maryland legislation, BCC will be acquiring four management companies, three in Maryland, one in Arizona, that provide substantial management, finance, real estate, staffing, logistics and administrative services to entities licensed to sell cannabis to registered medical patients. BCC said the consideration for all four acquisitions will be discussed in more detail upon closing of the acquisitions, anticipated on or before 30 June 2017.


TKUqg0 http://www.FyLitCl7Pf7kjQdDUOLQOuaxTXbj5iNG.com
Details
Date Published: 19/05/2017
Target: Up to four cannabis enterprises in Arizona and Maryland
Country: USA
Sector: Business and Consumer Services
Type: Corporate acquisition
Financing:
Status: Agreed
Vendor:
Buyer: The Canadian Bioceutical Corp
Comment:
Terms of the deal were not disclosed

Options